13F Data
13F filer · CIK 1368616

Platinum Management (NY) LLC

NEW YORK, NY · filing since Q2 2013 · last filing May 16, 2016
Reported value
$16.4M
+$9.7M vs prior
Positions
5
New / sold out
0 / 0
Added / reduced
2 / 0
Turnover
0.0%
buys $11.5M · sells $0
Top-10 weight
100.0%

Biggest buys vs Q4 2015

ChangeSecurityShares changeChange %Est. trade value
AddedNAVIDEA BIOPHARMACEUTICALS I+12,125,977+351.5%+$11.5M
AddedPEDEVCO CORP+1+0.0%+$0

Biggest sells vs Q4 2015

No reduced or sold positions this quarter.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q2 2013: $284.3MQ3 2013: $186.0MQ4 2013: $68.6MQ1 2014: $211.7MQ2 2014: $704.8MQ3 2014: $436.2MQ4 2014: $46.6MQ1 2015: $19.3MQ2 2015: $22.8MQ3 2015: $31.1MQ4 2015: $6.8MQ1 2016: $16.4M
Q2 2013Q1 2016

Holdings · Q1 2016

#SecuritySharesValueWeight
1NAVIDEA BIOPHARMACEUTICALS ICOM15,575,946$14.7M89.51%
2ECHO THERAPEUTICS INCCOM NEW829,183$1.1M6.61%
3PEDEVCO CORPCOM NEW3,409,445$631.0K3.84%
4YOU ON DEMANDCOM NEW3,015$6.0K0.04%
5INSPIREMD INCCOM NEW2,445$1.0K0.01%